T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD4OL interactions

Nature

Volumn 393, Issue 6684, 1998, Pages 480-483

  Schoenberger, Stephen P ^a   Toes, Rene E M ^a   Van Dervoort, Ellen I H ^a   Offringa, Rienk ^a   Melief, Cornells J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNOMODULATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032482474     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/31002     Document Type: Article

References (29)

1. Simpson, E. & Gordon, R. D. Responsiveness to H-Yantigcn. Ir-gene complementation and target cell specificity. Immunol Rev. 35,59-75 (1997).
2. Husmann, L. A. & Bevan, M. J. Cooperation between helper T cells and c>"totoxic T lymphocyte precursors. Ann. NYAcad. Sci. 532,158-169 (1983).
3. Bennelt, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P. & Heath, W. R. Induction of a CDS q-totoxîc T lymphocyte response by cross-priming requires cognate CD4+ T cell help, J. Exp. Med. 186,65-70(1997).
4. Keene, J. & Forman, J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Evp. AfoJ. 155, 768-782 (1982).
5. Guerder, S. & Matzinger, P. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Mcd. 176, 553-564(1992).
6. Grewal, I. S., Xu, J. & Flavell, R. A. Impairment of antigen-specific T-cell priming in mice lacking CD40 Hgand. Nature37S, 617-620 (1995).
7. van Essen, D., Kikutani, H. & Gray, D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378,620-623 (1995).
8. Koch, F. et al High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184, 741-746 (1996).
9. Cella, M. et al Lîgation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747-752 (1996).
10. Stout, R. D., SutUcs, J., Xu, J.-C, Grewal, I. S. & Flavell, R. A. Impaired T cell-mediated macrophage activation in CD40 Hgand-deficient mice. J. Immunol 156, 8-11 (1996).
11. Kennedy, M. K. et al Induction of B cell costimulatory function by recombinant murine CD40 ligand. EUT. J. Immunol 24, 116-123 (1994).
12. Toes, R. E. M. et al Protective anti-tumor immunity induced by immunization with completely allogcneic tumor cells. Cancer Res. 56,3782-3787 (1996).
13. Bcvan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic asay. J. Exp. Med. 143,1283-1288 (1976).
14. U. Huang, A. Y. et al Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264. 961-965 (1994).
15. Grewal, I. S. & Flavell, R. A. A central role of CD40 ligand in the regulation of CD4 T-cell responses. ImmunoL Today 17, 410-414 (1996).
16. Noëlle, R. CD40 and its ligand in host defense. Immunity 4, 415-419 (1996).
17. Soong, L étal Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4,263-273 (1996).
18. Mackey, M. F. et al Protective immunity induced by tumor vaccines requires interactions between CD40 and its ligand, CD154. Cancer Res. 57,2569-2574 (1997). "
19. Rolink, A., Mekhers, F. & Andersson, J. The SCID but not the RAG-2 gene product is required for the S mu-S epsilon heavy chain class switching. Immunity 5,319-330 (1996).
20. Grusby, M. J., Johnson, R. S., Papaioannou, V. E. & Glimcher, L H. Depletion of CD4+Tcells in major histocompatibility complex class II-deficienl mice. Science 253, 1417-1420 (1991).
21. Shinde, S. et ai CD4UL is important for induction of, but not response to, coslimulatory activity, I CAM-1 as the second costimulatory molecule rapidly upreguLited by CD40L. J. ItntnunoL 157,2764-2768(1996). ".
22. Kitamura, D., Roes, J., Kühn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the Membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426 (1991).
23. Noëlle, R, J. et al A 39-kDa protein on activated T helper cells binds CD-10 and transduces the signal for cognate activation of B cells. Proc. NatlAcad. Sci. USA 89, 6550-6554 (1992).
24. Yang, Y. & Wilson, J. M. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. SaVn273, 1862-1864 (1996).
25. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Anmi. Rev. Immunal. 9, 271-296(1991).
26. Mayordomo, J. I. et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Xaturc Meti. 1, 1297-1302 (1995).
27. Kurts, C, Kosaka, H., Carbone, F. R., Miller, J. F. A. P. & Heath, W. R. Class I-restricted crosspresentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J. Exp, Med. lS6t 239-245 (1997).
28. Kast, W. M. ct al Eradication of adenovirus El-induced tumors by Ela-specific Qtotoxic T l>-mphoc>tes. Cell 59,603-614 (1989).
29. Dialynas, D, P. et at Characterization of the murine T cell surface molecule, designated L3T4, identified by the monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol 131, 2445-2451 (1983).